摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 220135-31-9

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
220135-31-9
化学式
C19H43INiP2
mdl
——
分子量
522.069
InChiKey
IYHKSRCDYNJTEA-LPGALAGZSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    盐酸氘代苯 为溶剂, 生成 (1-Me-Ind)(PPh3)Ni-Cl
    参考文献:
    名称:
    茚基镍基咪唑配合物:合成,表征和反应性。
    摘要:
    制备了配合物(1-Me-茚基)Ni(PPh 3)(邻苯二甲酰亚胺酸酯),并通过IR和1 H,13 C { 1 H}和31 P { 1 H} NMR光谱和单晶X进行了全面表征射线衍射。还已经制备了类似的4,5-二氯邻苯二甲酰亚胺,马来酰亚胺和琥珀酰胺基络合物,并进行了光谱表征。与无法制备的类似Ni-酰胺基物质相比,这些配合物具有热稳定性。反应性研究表明,Ni-imidato键在插入和亲核反应以及VT 1中相当无反应。H NMR研究表明,马来酰亚胺络合物中Ni-N键周围的旋转受ca. 11 kcal / mol。邻苯二甲酰亚胺衍生物的固态结构表明,P,N,C1和C3原子在扭曲的方平面配位环境中排列在Ni原子周围,而C2原子在主方平面上方的键距内。所述phthalimidato配体为η 1(N)配位的成Ni; Ni-N键相对较短(1.895(4)Å),且酰亚胺配体的取向应使带有原子P,Ni,N和
    DOI:
    10.1021/om980653c
  • 作为产物:
    描述:
    (dtbpe)NiCl2 在 activated Mg 作用下, 以 四氢呋喃乙醚 为溶剂, 生成
    参考文献:
    名称:
    Synthesis, Structure, and Reactivity of (tBu2PC2H4PtBu2)Ni(CH3)2 and {(tBu2PC2H4PtBu2)Ni}2(μ-H)2
    摘要:
    Oxidative addition of CH3I to (d(t)bpe)Ni(C2H4) (d(t)bpe = (Bu2PC2H4PBu2)-Bu-t-Bu-t) affords (d(t)bpe)-Ni(I)CH3 (I). The reaction of (d(t)bpe)NiCl2 or 1 with the stoichiometric quantity of (tmeda)Mg(CH3), yields (d(t)bpe)Ni(CH3)(2) (2). (d(t)bpe)Ni(I)CD3 (1-d(3)) and (d(t)bpe)Ni(CD3)(2) (2-d(6)) have been prepared analogously. Thermolysis of 2 in benzene affords {(d(t)bpe)Ni}(2)(mu-eta(2):eta(2)-C6H6) (4). The reaction of either 2 or 4 with hydrogen (H-2, HD, D-2) gives {(d(t)bpe)Ni}(2)(mu-H)(2) (3) and the isotopomers {(d(t)bpe)Ni}(2)(mu-H)(mu-D) (3-d) and {(d(t)bpe)Ni}(2)(mu-D)(2) (3-d(2)). According to the NMR spectra, the structure of 3 is dynamic in solution. The crystal structures of 2 and 3 have been determined by X-ray crystallography, Solution thermolysis of 2 or reduction of (dtbpe)NiCl2 with Mg* in the presence of alkanes probably involves a-complex-type intermediates [(d(t)bpe)Ni(eta(2)-R'H)] (R' = e.g. C2H5, A). While the nonisolated [(d(t)bpe)Ni-0] a-complexes A are exceedingly reactive intermediates, isolated 3 and 4 represent easy to handle starting complexes for [(d(t)bpe)Ni-0] reactions. Partial protolysis of 2 with CF3SO3H affords (d(t)bpe)Ni(CH3)(OSO2CF3) (5). Complex 5 reacts slowly with 2 equiv of ethene to give equimolar amounts of [(d(t)bpe)Ni(C2H5)](+)(OSO2CF3-) (6) and propene. The reaction is thought to be initiated by an insertion of ethene into the Ni-CH3 bond of 5 to form the intermediate [(d(t)bpe)Ni(C3H7)(OSO2CF3)] (G), followed by elimination of propene to give the hydride intermediate [(d(t)bpe)Ni(H)(OSO2CF3)] (H), which on insertion of ethene into the Ni-H bond affords 6.
    DOI:
    10.1021/om980705y
点击查看最新优质反应信息

同类化合物

磷杂环戊-3-烯 9-磷杂二环[3.3.1]壬烷 4,8-二甲基-2-磷酸双环[3.3.1]壬烷 3,3-二甲基-1,2-二叔-丁基-二磷杂环丙烷 2-氧杂环烷酮,均聚物,氧代二-2,1-乙二基酯 1,3,4-三甲基-delta(3)-磷杂环戊烯-1,1-二氯化物 1,1,3,3-四(二甲基氨基)-1,3-二磷杂环丁二烯 1-Chlor-3,4-dimethyl-2(3)-phospholen {NiBr2-1.2-Bis-dimethylphosphino-aethan}Br cyclohex-1-enylphosphonic difluoride trans-2-Ethyl-phosphiran β-[PNtBu]4 (Z)-Cyclooctene; compound with bromine bis{1,2-bis(dimethylphosphino)ethane}di-iodoiron 2,4-di-tert.-butyl-1,1-dimethyl-1-stanna-2,5-cyclohexadiene [Pt(hydride)(1,2-bis(diethylphosphino)ethane)2](hexafluorophosphate) 2,3,4,5,6,7-hexamethyl-9,10,11,12-tetrakis(trifluoromethyl)-1,8-diphosphatetracyclo<6.2.2.02,7.03,6>dodeca-4,9,11-triene bis(triethylphosphine)-2,4,4-trimethylplatinacyclopentane Zr[TeSi(SiMe3)3]2(Te)(1,2-bis(dimethylphosphino)ethane)2 2,3-bis-trifluoromethyl-1-phospha-bicyclo[2.2.2]octa-2,5,7-triene 5-methoxy-2,2,3,3,7-pentamethyl-1,4,6-trioxa-5λ5-phospha-spiro[4.4]non-7-ene 3,4-Bis(2,2,3,3,4,4,5,5-decafluorpentyl)-1,2-dithiet 1,2,3,4,5-Pentamethyl-phosphole 1-oxide [n-BuB(CH2P-i-Pr2)3Ag(triethylphosphine)] 1-tert-butyl-3-phospholene brominanium 2,6,10,14-Tetramethyl-1,3,9,11-tetraoxa-2,6,10,14-tetraphospha-cyclohexadecane 2,6,10,14-tetrasulfide bis(triethylphosphine)-3,3-dimethylplatinacyclobutane 1,4,9,12-tetramethyl-1,4,9,12-tetraphosphacyclohexadeca-6,4-diene 1,4,9,12-tetraoxyde 1-methyl-octahydro-1-phospha-2,3-cyclo-dicyclopropa[a,cd]pentalene 1-oxide cis-2,6-dimethyl-1,3-dioxa-2,6-diphosphacyclo-octane 2,6-disulphide N-butyl-N-(3,4-dimethyl-1-oxo-2,5-dihydro-1lambda5-phosphol-1-yl)-3,4-dimethyl-1-oxo-2,5-dihydro-1lambda5-phosphol-1-amine oxolane;triiodovanadium trans-2,6-dimethyl-1,3-dioxa-2,6-diphosphacyclo-octane 2,6-disulphide 2,6-Dimethyl-[1,2,6]oxadiphosphinane 2,6-dioxide 1-cyclohexyl-phospholane 1-sulfide 1,4-Dicyclohexyl-2,2,3,3,5,5,6,6-octamethyl-[1,4,2,3,5,6]diazatetrasilinane 1-Chloro-2-methyl-phosphole 1-oxide 1-Isopropenyltellanyl-butane 2-Dimethylphosphanylethyl(dimethyl)phosphane;tetraiodohafnium 2,7-Dimethyl-[1,2,7]oxadiphosphepane 2,7-dioxide 9-methyl-(1rP,2cH,5cH,6cP)-9-phospha-tricyclo[4.2.1.02,5]nonane 9ξ-oxide bismethano-nickelacyclotridecahexaene ethylthiolato(methyl)(1,2-bis(diisopropylphosphino)ethane)platinum(II) 1-Chloro-2-methyl-phosphole 1-sulfide